13F Data
13F filer · CIK 1674712

Vivo Capital, LLC

Palo Alto, CA · filing since Q1 2016 · last filing Aug 14, 2026
Reported value
$1.1B
$-107.9M vs prior
Positions
47
New / sold out
7 / 6
Added / reduced
6 / 8
Turnover
13.6%
buys $155.7M · sells $353.8M
Top-10 weight
52.4%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedTenax Therapeutics Inc+2,291,667+1100.0%+$33.3M
AddedArrivent BioPharma Inc+796,181+89.9%+$27.7M
AddedAbivax SA - ADR+175,360+73.2%+$23.4M
NewAchieve Life Sciences Inc.+2,751,032–+$18.0M
NewEditas Medicine Inc+3,555,250–+$11.5M
NewOdyssey Therapeutics Inc+575,000–+$10.8M
NewAura Biosciences Inc+1,166,667–+$8.3M
AddedMoonlake Immunotherapeutics+400,000+40.0%+$7.8M
NewAvalo Therapeutics Inc+275,000–+$5.1M
AddedAlto Neuroscience Inc+173,307+16.7%+$4.6M
3 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedErasca Inc-8,024,068-66.0%$-147.0M
Sold outTerns Pharmaceuticals Inc-1,334,418-100.0%$-70.4M
ReducedTango Therapeutics Inc-775,011-36.0%$-24.2M
ReducedPraxis Precision Medicines-67,779-20.0%$-22.7M
Sold outVeradermics Inc-300,000-100.0%$-18.9M
Sold outCogent Biosciences Inc-422,300-100.0%$-16.3M
ReducedSAB Biotherapeutics Inc-4,120,091-36.1%$-16.1M
ReducedDBV Technologies SA-822,811-30.8%$-13.5M
Sold outSoleno Therapeutics Inc-294,909-100.0%$-9.9M
ReducedUnicycive Therapeutics-1,239,916-69.3%$-5.8M
4 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q1 2016: $398.7MQ2 2016: $366.2MQ3 2016: $320.9MQ4 2016: $303.5MQ1 2017: $339.9MQ2 2017: $397.1MQ3 2017: $494.8MQ4 2017: $466.9MQ1 2018: $705.9MQ2 2018: $776.1MQ3 2018: $992.2MQ4 2018: $783.1MQ1 2019: $1.0BQ2 2019: $1.1BQ3 2019: $878.8MQ4 2019: $1.4BQ1 2020: $1.1BQ2 2020: $1.4BQ3 2020: $1.7BQ4 2020: $2.2BQ1 2021: $2.8BQ2 2021: $2.3BQ3 2021: $2.2BQ4 2021: $1.7BQ1 2022: $1.5BQ2 2022: $995.9MQ3 2022: $905.8MQ4 2022: $868.5MQ1 2023: $1.4BQ2 2023: $1.4BQ3 2023: $912.8MQ4 2023: $1.2BQ1 2024: $1.3BQ2 2024: $1.1BQ3 2024: $1.2BQ4 2024: $892.6MQ1 2025: $755.1MQ2 2025: $977.1MQ3 2025: $1.2BQ4 2025: $1.5BQ1 2026: $1.2BQ2 2026: $1.1B
Q1 2016Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1Trevi Therapeutics IncCOMMON5,094,668$95.0M8.68%
2Praxis Precision MedicinesCOMMON271,116$90.8M8.29%
3Erasca IncCOMMON4,127,412$75.6M6.90%
4Arrivent BioPharma IncCOMMON1,682,097$58.4M5.34%
5Abivax SA - ADRSPONSORED ADS414,899$55.3M5.05%
6Tango Therapeutics IncCOMMON1,379,769$43.1M3.94%
7Corvus Pharmaceuticals IncCOMMON2,805,816$41.9M3.83%
8Bright Minds Biosciences IncCOMMON557,172$39.1M3.57%
9Sinovac Biotech Ltd.SHS5,903,000$38.2M3.49%
10Tenax Therapeutics IncCOMMON2,500,000$36.4M3.32%
37 more rows. Subscribe for $29/month to see every row, download the data and use the API.